Commonly prescribed beta blockers used to treat conditions such as hypertension, angina and migraine do not cause depression, according to a Roselie Bright and Daniel Everitt of Beth Israel Hospital, Boston.
Writing in the Journal of the American Medical Association, they cite a number of reports suggesting that use of these drugs was linked to the development of clinical depression, and events such as nightmares, impotence and hallucinations.
Using Medicaid claims from New Jersey between July 1980 and December 1983, Drs Brights and Everitt identified 4,302 patients who had at least one marker for depression: use of antidepressant drugs, in-hospital depression diagnosis, or electroconvulsive therapy. Two control patients were assigned to each case patient, matched for date of first depression marker, birth year, sex, race and nursing home residency status.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze